-
While I'm sure you're right, what Big Pharma company would want to be competing with a rival that's (nearly) as effective as yours, is cheaper and much easier to store, to boot?
But there again, if this article in the Graun
https://amp-theguardian-com.cdn.ampproject.org/v/s/amp.theguardian.com/world/2020/nov/26/scrutiny-grows-over-oxford-universityastrazeneca-vaccine?amp_js_v=a6&_gsa=1&usqp=mq331AQFKAGwASA%3D#aoh=16064218925627&csi=1&referrer=https%3A%2F%2Fwww.google.com&_tf=From %251%24s&share=https%3A%2F%2Fwww.theguardian.com%2Fworld%2F2020%2Fnov%2F26%2Fscrutiny-grows-over-oxford-universityastrazeneca-vaccine
is even half true it sounds like someone at AstralZenecal didn't read the brief regarding FDA spprovalCritics have also claimed the trials did not include enough ethnic diversity, gender and age balance to satisfy the US regulator, the Food and Drug Administration
You are reading a single comment by @dubtap and its replies.
Click here to read the full conversation.
Cutthroat_Jake
@dubtap
Good to see Astra Zeneca trial results being trashed in the US press who definitely have not been given a nudge by Pfizer
https://www.nytimes.com/2020/11/25/business/coronavirus-vaccine-astrazeneca-oxford.html